{
    "2021-10-14": [
        [
            {
                "time": "2023-10-15",
                "original_text": "Lilly Announces Updated VerzenioÂ® (abemaciclib) Phase 3 monarchE Trial Data Presented at ESMO Virtual Plenary and Simultaneously Published in the Annals of Oncology",
                "features": {
                    "keywords": [
                        "Verzenio",
                        "Phase 3",
                        "monarchE",
                        "ESMO",
                        "Annals of Oncology"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-15",
                "original_text": "Scientist behind Vertex CF drugs launches new startup with Atlas Venture",
                "features": {
                    "keywords": [
                        "Vertex",
                        "CF drugs",
                        "startup",
                        "Atlas Venture"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}